Recombinant MPXV A29L Component (His Label): A Scientific Resource
Recombinant MPXV A29L Component (His Label): A Scientific Resource
Blog Article
This produced Orthopoxvirus A29L component, equipped with a His marker, represents a valuable scientific resource for investigation of Orthopoxvirus mechanisms and candidate therapeutic targets. The His tag allows for easy separation and assessment using conventional immobilized techniques, making it appropriate for a range of experiments including receptor binding assays, structure analysis, and component production studies. Thus, this engineered molecule offers a reliable means to promote understanding of Orthopoxvirus biology.
Production and Characterization of Recombinant MPXV A29L Protein (His Tag)
The successful generation of recombinant MPXV A29L polypeptide, modified with a His tag, was obtained using *E. coli* transcription system. Preliminary procedures involved cloning the A29L DNA into a pet vector followed by introduction into competent *E. coli* cells. Subsequently, optimized growth conditions were defined to maximize yield. Isolation of the His-tagged A29L molecule was executed utilizing immobilized metal affinity chromatography. Analysis involved approaches such as SDS-PAGE, antibody blotting, and mass analysis to verify identity and assess apparent weight and purity. The isolated recombinant A29L molecule showed appropriate size and suggested the presence of the His label, confirming adequate generation and purification.
Recombinant Monkeypox Virus A29L Antigen (His Tag|with a His-tag|His-tagged) for MPXV Investigations
The availability of recombinant MPXV A29L antigen (His Tag) is a critical reagent for advancing investigations into the pathogenesis of monkeypox disease. This protein facilitates simple quantification and purification through His chromatography, permitting for detailed characterization of its functional properties, interaction with host factors, and role in viral entry. The His label acts as a convenient handle for easy generation and cleansing, making it particularly suited for the range of MPXV analyses.
Improving Synthesis of Expressed MPXV A29L Factor (His Tag | with a His Tag | tagged with His | featuring a His tag)
To achieve high yields of the expressed MPXV A29L factor , several parameters require meticulous regulation. Early attempts involved conventional production in *E. coli*, however, this often resulted in limited yields and considerable inclusion body formation. Thus, techniques such as changing the signal strength, adjusting the incubation conditions , and employing chaperone co-factors to facilitate proper arrangement were employed . Additionally , exploring other expression hosts , such as cells, is currently examined to even enhance production and enhance factor integrity .
Applications of Recombinant MPXV A29L Protein (His Tag) in Diagnostics
Recombinant MPXV A29L molecule (His tag) holds significant promise in developing reliable diagnostic tests for MPXV virus. Its use as a epitope in ELISA and lateral detection systems enables for specific binding of antibodies from affected individuals. The His marker facilitates purification and identification of the recombinant A29L molecule, therefore boosting the overall performance and accuracy of the detection process. Further study into its integration into multiplex diagnostic arrays remains a encouraging field of exploration.
Recombinant Orthopoxvirus A29L Protein (His Tag) Stock and Details
The engineered A29L protein from Monkeypox, featuring a His-tag for easy recovery, is now available for scientific use. This particular item is expressed in E. coli and provided as a freeze-dried form, permitting for long-term keeping. Standard specifications include a weight of approximately 140 Recombinant MPXV A29L Protein(His Tag) kDa, >90% homogeneity as evaluated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and a concentration of 1 mg/ml in a buffer of phosphate-buffered saline. Refer to the data guide for full data regarding transport conditions and suggested keeping protocols.
Report this page